Church vs clinic: which helps black adults with alcohol problems more?

NCT ID NCT04580810

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study compares two ways to treat alcohol use disorder in Black adults: a computer-based therapy offered in a Black church versus traditional care at a specialty clinic. Researchers want to see which setting gets more people to start and stay in treatment, and leads to more days without drinking. The study involves 137 participants and follows them for up to 9 months.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Computer-based cognitive behavioral therapy (CBT4CBT) delivered in a Black church setting
What this could lead to
If successful, this could show that offering alcohol treatment in familiar community settings like churches improves access and outcomes for Black adults with alcohol use disorder.
What could go wrong
This is a relatively small study (137 participants) comparing settings, not testing a new drug or cure. Results may not apply to other communities or settings, and the intervention is behavioral, so individual results vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beulah Heights First Pentecostal Church

    New Haven, Connecticut, 06511, United States

  • Dixwell Ave Congregational United Church of Christ

    New Haven, Connecticut, 06511, United States

  • The Substance Abuse Training Unit (SATU)

    New Haven, Connecticut, 06511, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.